|
|
Previous Article | Table of Contents | Next Article 
Effect of c-kit ligand on in vitro human megakaryocytopoiesis
RA Briddell, E Bruno, RJ Cooper, JE Brandt and R Hoffman
Department of Medicine, Indiana University School of Medicine,
Indianapolis.
An evaluation of the effects of a recombinant, soluble form of the c- kit
ligand alone and in combination with either granulocyte-macrophage
colony-stimulating factor (GM-CSF) or interleukin-3 (IL-3) on the
regulation of human megakaryocytopoiesis was performed using a serum-
depleted clonal assay system and a long-term bone marrow culture system.
The effects of the c-kit ligand on the primitive megakaryocyte (MK)
progenitor cell, the burst-forming unit-megakaryocyte (BFU-MK), and the
more differentiated colony-forming unit-megakaryocyte (CFU-MK) were
determined. The c-kit ligand alone had no megakaryocyte colony- stimulating
activity (MK-CSA) but was capable of augmenting the MK-CSA of both GM-CSF
and IL-3. The range of synergistic interactions of c-kit ligand varied with
the class of MK progenitor cell assayed. In the case of the BFU-MK, the
c-kit ligand synergistically augmented the numbers of colonies formed in
the presence of IL-3, but not GM-CSF, but increased the size of
BFU-MK-derived colonies cloned in the presence of both of these cytokines.
However, at the level of the CFU-MK, c-kit ligand synergized with both
GM-CSF and IL-3 by increasing both colony numbers and size. Although the
c-kit ligand alone exhibited limited potential in sustaining long-term
megakaryocytopoiesis in vitro, it synergistically augmented the ability of
IL-3, but not GM-CSF, to promote long-term megakaryocytopoiesis. These data
indicate that multiple cytokines are necessary to optimally stimulate the
proliferation of both classes of MK progenitor cells and that the c-kit
ligand plays a significant role in this process by amplifying the MK- CSA
of both GM-CSF and IL-3.
Volume 78,
Issue 11,
pp. 2854-2859,
12/01/1991
Copyright © 1991 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Taniguchi, R. London, K. Schinkmann, S. Jiang, and H. Avraham
The Receptor Protein Tyrosine Phosphatase, PTP-RO, Is Upregulated During Megakaryocyte Differentiation and Is Associated With the c-Kit Receptor
Blood,
July 15, 1999;
94(2):
539 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Mattapallil, Z. Smit-McBride, and S. Dandekar
Gastrointestinal Epithelium Is an Early Extrathymic Site for Increased Prevalence of CD34+ Progenitor Cells in Contrast to the Thymus during Primary Simian Immunodeficiency Virus Infection
J. Virol.,
May 1, 1999;
73(5):
4518 - 4523.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Kaushansky
Thrombopoietin
N. Engl. J. Med.,
September 10, 1998;
339(11):
746 - 754.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Williams, G. G. Pipia, N. S. Datta, and M. W. Long
Thrombopoietin Requires Additional Megakaryocyte-Active Cytokines for Optimal Ex Vivo Expansion of Megakaryocyte Precursor Cells
Blood,
June 1, 1998;
91(11):
4118 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bruno, S. K. Horrigan, D. Van Den Berg, E. Rozler, P. R. Fitting, S. T. Moss, C. Westbrook, and R. Hoffman
The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-beta on Human Hematopoiesis
Blood,
March 15, 1998;
91(6):
1917 - 1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Nocka, B. A. Levine, J.-L. Ko, P. M. Burch, B. E. Landgraf, R. Segal, and R. Lobell
Increased Growth Promoting But Not Mast Cell Degranulation Potential of a Covalent Dimer of c-Kit Ligand
Blood,
November 15, 1997;
90(10):
3874 - 3883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hiregowdara, H. Avraham, Y. Fu, R. London, and S. Avraham
Tyrosine Phosphorylation of the Related Adhesion Focal Tyrosine Kinase in Megakaryocytes upon Stem Cell Factor and Phorbol Myristate Acetate Stimulation and Its Association with Paxillin
J. Biol. Chem.,
April 18, 1997;
272(16):
10804 - 10810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ayala, A Tomer, and K. Kellar
Flow cytometric analysis of megakaryocyte-associated antigens on CD34 cells and their progeny in liquid culture
Stem Cells,
May 1, 1996;
14(3):
320 - 329.
[Abstract]
|
 |
|

|
 |

|
 |
 
A Ritchie, S Vadhan-Raj, and H. Broxmeyer
Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line, M07e
Stem Cells,
May 1, 1996;
14(3):
330 - 336.
[Abstract]
|
 |
|

|
 |

|
 |
 
B. H. Jhun, B. Rivnay, D. Price, and H. Avraham
The MATK Tyrosine Kinase Interacts in a Specific and SH2-dependent Manner with c-Kit
J. Biol. Chem.,
April 21, 1995;
270(16):
9661 - 9666.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|